New insights into the role of soluble guanylate cyclase in blood pressure regulation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current opinion in nephrology and hypertension

• Publication date

  2014-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/01.mnh.0000441048.91041.3aPMID 24419369PMCID PMC4102174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.

  2013cited by this paper
• The trans effect of nitroxyl (HNO) in ferrous heme systems: implications for soluble guanylate cyclase activation by HNO.

  2013cited by this paper
• Pathophysiology of Hypertension in the Absence of Nitric Oxide/Cyclic GMP Signaling

  2013cited by this paper
• Functional remodelling of arterial endothelium during early postnatal development in rats.

  2013cited by this paper
• Genetic modification of hypertension by sGCα1.

  2013cited by this paper
• Mechanisms of the vasorelaxing effects of CORM-3, a water-soluble carbon monoxide-releasing molecule: interactions with eNOS

  2013cited by this paper
• Mechanism of Inhibition of Tubuloglomerular Feedback by CO and cGMP

  2013cited by this paper
• Thrombin Has Biphasic Effects on the Nitric Oxide-cGMP Pathway in Endothelial Cells and Contributes to Experimental Pulmonary Hypertension

  2013cited by this paper
• Crystal Structures of the Catalytic Domain of Human Soluble Guanylate Cyclase

  2013cited by this paper
• Dynamic Change of Heme Environment in Soluble Guanylate Cyclase and Complexation of NO‐Independent Drug Agents with H‐NOX Domain

  2013cited by this paper
• Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure.

  2013cited by this paper
• Endothelium-Derived Nitric Oxide Supports Renin Cell Recruitment Through the Nitric Oxide–Sensitive Guanylate Cyclase Pathway

  2013cited by this paper
• Assessing murine resistance artery function using pressure myography.

  2013cited by this paper
• Insights into BAY 60-2770 activation and S-nitrosylation-dependent desensitization of soluble guanylyl cyclase via crystal structures of homologous nostoc H-NOX domain complexes.

  2013cited by this paper
• Chronic oxidative-nitrosative stress impairs coronary vasodilation in metabolic syndrome model rats.

  2013cited by this paper
• Orexin A regulates cardiovascular responses in stress-induced hypertensive rats.

  2013cited by this paper
• Endothelial dysfunction and systemic hypertension by selective cGMP-dependent protein kinase I inhibition using novel cell-penetrating peptide delivered in vivo.

  2013cited by this paper
• Medial prefrontal cortex N‐methyl‐D‐aspartate receptor/nitric oxide/cyclic guanosine monophosphate pathway modulates both tachycardic and bradycardic baroreflex responses

  2013cited by this paper
• Treatment of pulmonary hypertension caused by left heart failure with pulmonary arterial hypertension-specific therapies: lessons from the right and LEPHT.

  2013cited by this paper
• The ventral hippocampus NMDA receptor/nitric oxide/guanylate cyclase pathway modulates cardiovascular responses in rats.

  2013cited by this paper
• The vasorelaxant effects of 1-nitro-2-phenylethane involve stimulation of the soluble guanylate cyclase-cGMP pathway.

  2013cited by this paper
• Endothelial Nitric Oxide Synthase-Independent Release of Nitric Oxide in the Aorta of the Spontaneously Hypertensive Rat

  2013cited by this paper
• Nitric Oxide- and Heme-Independent Activation of Soluble Guanylate Cyclase Attenuates Peroxynitrite-Induced Endothelial Dysfunction in Rat Aorta

  2013cited by this paper
• Receptor binding assay for NO-independent activators of soluble guanylate cyclase.

  2013cited by this paper
• Cyclic guanosine monophosphate and the dependent protein kinase regulate lymphatic contractility in rat thoracic duct

  2013cited by this paper
• Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.

  2013cited by this paper
• Riociguat for the treatment of pulmonary arterial hypertension.

  2013cited by this paper
• Direct sGC Activation Bypasses NO Scavenging Reactions of Intravascular Free Oxy-Hemoglobin and Limits Vasoconstriction

  2013cited by this paper
• Higher-order interactions bridge the nitric oxide receptor and catalytic domains of soluble guanylate cyclase

  2013cited by this paper
• Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators.

  2013cited by this paper
• Sulfhydryl-dependent Dimerization and cGMP-mediated Vasodilatation

  2013cited by this paper
• Pharmacological Characterization of 1-Nitrosocyclohexyl Acetate, a Long-Acting Nitroxyl Donor That Shows Vasorelaxant and Antiaggregatory Effects

  2013cited by this paper
• The Effects of Cyclic Guanylate Cyclase Stimulation on Right Ventricular Hypertrophy and Failure Alone and in Combination With Phosphodiesterase-5 Inhibition

  2013cited by this paper
• The role of oxidative stress in acetylcholine-induced relaxation of endothelium-denuded arteries.

  2013cited by this paper
• Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity.

  2013cited by this paper
• A soluble guanylate cyclase stimulator, BAY 41-8543, preserves right ventricular function in experimental pulmonary embolism.

  2013cited by this paper
• Oxygen Mediates Vascular Smooth Muscle Relaxation in Hypoxia

  2013cited by this paper
• Reciprocal Relationship Between Reactive Oxygen Species and Cyclooxygenase-2 and Vascular Dysfunction in Hypertension

  2013cited by this paper
• p53 Orchestrates the PGC-1α-Mediated Antioxidant Response Upon Mild Redox and Metabolic Imbalance

  2013cited by this paper
• Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation.

  2013cited by this paper
• HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.

  2013cited by this paper
• Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study

  2013cited by this paper
• Soluble guanylate cyclase modulates alveolarization in the newborn lung.

  2013cited by this paper
• Increased caveolae density and caveolin-1 expression accompany impaired NO-mediated vasorelaxation in diet-induced obesity

  2013cited by this paper
• Sulfhydryl-dependent dimerization of soluble guanylyl cyclase modulates the relaxation of porcine pulmonary arteries to nitric oxide

  2012cited by this paper
• Relaxant Effect of a Water Soluble Carbon Monoxide-Releasing Molecule (CORM-3) on Spontaneously Hypertensive Rat Aortas

  2012cited by this paper
• Abstract 489: Mechanisms of Carbon Monoxide Attenuation of Tubuloglomerular Feedback

  2012cited by this paper
• sGC stimulation totally reverses hypoxia‐induced pulmonary vasoconstriction alone and combined with dual endothelin‐receptor blockade in a porcine model

  2012cited by this paper
• Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial

  2012cited by this paper
• Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design

  2012cited by this paper
• Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses.

  2012cited by this paper
• Sodium Depletion Enhances Renal Expression of (Pro)Renin Receptor via Cyclic GMP-Protein Kinase G Signaling Pathway

  2012cited by this paper
• Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.

  2012cited by this paper
• Intrarenal Angiotensin III Is the Predominant Agonist for Proximal Tubule Angiotensin Type 2 Receptors

  2012cited by this paper
• Dietary obesity increases NO and inhibits BKCa-mediated, endothelium-dependent dilation in rat cremaster muscle artery: association with caveolins and caveolae.

  2012cited by this paper
• Heme-assisted S-Nitrosation Desensitizes Ferric Soluble Guanylate Cyclase to Nitric Oxide*

  2012cited by this paper
• Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension.

  2012cited by this paper
• Structure and regulation of soluble guanylate cyclase.

  2012cited by this paper
• Crosstalk between central pathways of nitric oxide and carbon monoxide in the hypertensive action of cyclosporine.

  2012cited by this paper
• Trial watch: Phase III success for first-in-class pulmonary hypertension drug

  2012cited by this paper
• Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.

  2012cited by this paper
• Impaired lymphatic contraction associated with immunosuppression

  2011cited by this paper
• Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.

  2011cited by this paper
• Endothelial Dysfunction Enhances Vasoconstriction Due to Scavenging of Nitric Oxide by a Hemoglobin-based Oxygen Carrier

  2010cited by this paper
• Soluble Guanylate Cyclase &agr;1&bgr;1 Limits Stroke Size and Attenuates Neurological Injury

  2010cited by this paper
• sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.

  2009cited by this paper
• Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.

  2008cited by this paper
• Nitroglycerin-Induced S-nitrosylation and Desensitization of Soluble Guanylyl Cyclase Contribute to Nitrate Tolerance

  2008cited by this paper
• Cardiovascular-Renal Mechanisms in Health and Disease Acute antihypertensive action of Tempol in the spontaneously hypertensive rat

  2007cited by this paper
• Desensitization of soluble guanylyl cyclase, the NO-receptor, by S-nitrosylation

  2007cited by this paper
• NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

  2006cited by this paper
• Characterization of the Mechanism of Cytochrome P450 Reductase-Cytochrome P450-mediated Nitric Oxide and Nitrosothiol Generation from Organic Nitrates*

  2006cited by this paper
• Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system.

  2006cited by this paper

• Targeting the Gut in Sepsis: Therapeutic Potential of Medical Gases.

  2026cites this paper
• Dissection of no binding pathway in nitrobindins reveals hidden structural details.

  2025cites this paper
• Oral Toxicity and Hypotensive Influence of Sericin-Derived Oligopeptides (SDOs) from Yellow Silk Cocoons of Bombyx mori in Rodent Studies

  2024cites this paper
• A benzimidazole-based Cu(II) complex catalyzed site-selective C-H sulfenylation of imidazo-[1,2-a]pyridines using CS2 as a sulfur source.

  2024cites this paper
• Nitric Oxide Binding Geometry in Heme-Proteins: Relevance for Signal Transduction

  2024cites this paper
• Orthostatic hypotension is associated with higher levels of circulating endostatin

  2024cites this paper
• Regional variations in allergen‐induced airway inflammation correspond to changes in soluble guanylyl cyclase heme and expression of heme oxygenase‐1

  2024cites this paper
• Genetic Variants Associated with Hypertension Risk: Progress and Implications

  2024cites this paper
• Arterial Hypertension: Novel Pharmacological Targets and Future Perspectives

  2024influential citation
• Systematic characterization of regulatory variants of blood pressure genes

  2023cites this paper
• Regions of Inflammation in mouse asthma correspond to regions of heme-free soluble guanylyl cyclase and can be tracked by marked expression of heme-oxygenase-1

  2023cites this paper
• Role of the Coiled-Coil Domain in Allosteric Activity Regulation in Soluble Guanylate Cyclase.

  2023cites this paper
• Assessment of ability of AlphaMissense to identify variants affecting susceptibility to common disease

  2023cites this paper
• Analysis of Rare Variants in 470,000 Exome-Sequenced UK Biobank Participants Implicates Novel Genes Affecting Risk of Hypertension

  2023cites this paper
• Randomized placebo‐controlled crossover study to assess tolerability and pharmacodynamics of zagociguat, a soluble guanylyl cyclase stimulator, in healthy elderly

  2023cites this paper
• Identification and characterization of the new generation sGC stimulator BAY 1165747 (BAY-747) designed for the treatment of resistant hypertension.

  2023cites this paper
• Ammodaucus leucotrichus acts as an antihypertensive and vasorelaxant agent through sGC and prostaglandin synthesis pathways.

  2022cites this paper
• Whole body metabolism is improved by hemin added to high fat diet while counteracted by nitrite: a mouse model of processed meat consumption.

  2021cites this paper
• Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase

  2021cites this paper
• Analysis of 200,000 Exome-Sequenced UK Biobank Subjects Implicates Genes Involved in Increased and Decreased Risk of Hypertension

  2021cites this paper
• Cytosolisch guanylaatcyclase als therapeutisch target

  2021cites this paper
• Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation

  2021cites this paper
• An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome

  2021cites this paper
• The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer

  2021cites this paper
• Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension

  2021cites this paper
• Population genomics of honey bees reveals a selection signature indispensable for royal jelly production.

  2020cites this paper
• Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.

  2020cites this paper
• An inherent dysfunction in soluble guanylyl cyclase is present in the airway of severe asthmatics and is associated with aberrant redox enzyme expression and compromised NO-cGMP signaling

  2020cites this paper
• Aqueous extract of oakmoss produces antihypertensive activity in L-NAME-induced hypertensive rats through sGC-cGMP pathway

  2020cites this paper
• Nitric Oxide in Hematological Cancers: Partner or Rival?

  2020cites this paper
• NO donors induce vascular relaxation by different cellular mechanisms in hypertensive and normotensive rats.

  2019cites this paper
• Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction.

  2018cites this paper
• YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts

  2018cites this paper
• Gaseous Signaling Molecules in Cardiovascular Function: From Mechanisms to Clinical Translation.

  2018cites this paper
• Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor

  2017cites this paper
• Regulation of sGC via hsp90, Cellular Heme, sGC Agonists, and NO: New Pathways and Clinical Perspectives

  2017cites this paper
• Carbon disulfide. Just toxic or also bioregulatory and/or therapeutic?

  2017cites this paper
• Genome-Wide microRNA Binding Site Variation between Extinct Wild Aurochs and Modern Cattle Identifies Candidate microRNA-Regulated Domestication Genes

  2017cites this paper
• Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies.

  2016cites this paper
• Small molecule and peptide therapies for chronic heart failure: a patent review (2011 – 2014)

  2015cites this paper
• Fatty acid analysis and regulatory effects of citron (Citrus junos Sieb. ex TANAKA) seed oil on nitric oxide production, lipid accumulation, and leptin secretion

  2014cites this paper